Features of the hormonal profile in obese reproductive-age women
https://doi.org/10.23946/2500-0764-2020-5-3-77-84
Abstract
Aim. To assess the hormonal profile features in obese reproductive-age women.
Materials and Methods. We consecutively enrolled 163 women of reproductive age (140 women with body mass index ≥ 30 kg/m2 and 23 women with normal body mass index) who have been admitted to Podgorbunskiy Regional Emergency Medicine Hospital. All patients of both groups underwent general and gynecological examination. Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, estradiol, estrone, testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone, free triiodothyronine, total and free thyroxine, cortisol, leptin, immunoreactive insulin, and progesterone were assessed on days 5-6 and 21-22 of the menstrual cycle.
Results. Obese women of reproductive age were characterised by higher values of LH, LH/ FSH ratio, testosterone, estradiol, estrone, leptin, IRI and by lower levels of FSH and progesterone compared with normal weight women. A direct correlation was found between the level of leptin and estrone (r = 0.21, p = 0.014), insulin resistance (r = 0.18, p = 0.039), triglycerides (r = 0.20, p = 0.030), and low-density lipoprotein cholesterol (r = 0.22, p = 0.016). There was a statistically significant inverse correlation between the level of leptin and high-density lipoprotein cholesterol (r = -0.18, p = 0.043). A direct correlation was established between insulin and LH (r = 0.24, p = 0.030), testosterone (r = 0.32, p = 0.037), dehydroepiandrosterone sulfate (r = 0.56, p = 0.003), insulin resistance (r = 0.95, p < 0.001), cholesterol (r = 0.20, p = 0.024), triglycerides (r = 0.29, p < 0.001).
Conclusion. Obese women of reproductive age have certain hormonal features that underlie menstrual and reproductive disorders in these patients.
About the Authors
N. V. ArtymukRussian Federation
Prof. Natalia V. Artymuk, MD, DSc, Professor, Head of the Department of Obstetrics and Gynecology
22a, Voroshilova Street, Kemerovo, 650056
O. A. Tachkova
Russian Federation
Dr. Olga A. Tachkova, MD, PhD, Associate Professor, Department of Internal Medicine and Clinical Pharmacology
22a, Voroshilova Street, Kemerovo, 650056
N. A. Sukhova
Russian Federation
Dr. Natalia A. Sukhova, MD, PhD, Associate Professor, Department of Internal Medicine and Clinical Pharmacology
22a, Voroshilova Street, Kemerovo, 650056
References
1. Murthy AS. Obesity and contraception: emerging issues. Semin Reprod Med. 2010;28(2):156-163. https://doi.org/10.1055/s-0030-1248141
2. Hoffmann K, De Gelder R, Hu Y, Bopp M, Vitrai J, Lahelma E. Menvielle G, Santana P, Regidor E, Ekholm O, Mackenbach JP, van Lenthe FJ. Trends in educational inequalities in obesity in 15 European countries between 1990 and 2010. Int J Behav Nutr Phys Act. 2017;14(1):63. https://doi.org/10.1186/s12966-017-0517-8
3. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over the life course and obesity: systematic review and metaanalysis. PLoS One. 2017;12(5): e0177151. https://doi.org/10.1371/journal.pone.0177151
4. Wagner KJ, Bastos JL, Navarro A, Boing AF. Socio-economic life course and obesity among adults in Florianopolis, southern Brazil. Gac Sanit. 2018;32(3): 244-250. https://doi.org/10.1016/j.gaceta.2017.01.006
5. Артымук Н.В., Тачкова О.А., Шурыгин С.Н. «Порочный репродуктивный круг» ожирения: обзор литературы. Доктор. Ру. 2018;10(154):22-26 [Artymuk NV, Tachkova OA, Shurygin SN. The Reproductive Vicious Cycle of Obesity: Review of the Literature. Doctor.Ru. 2018;10(154):22-26. (In Russ.).] https://doi.org/10.31550/1727-2378-2018-154-10-22-26
6. Seif MW, Diamond K, Nickkho-Amiry M. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2015;29(4):516- 527. https://doi.org/10.1016/j.bpobgyn.2014.10.010
7. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017;107(4):840-847. https://doi.org/10.1016/j.fertnstert.2017.01.017
8. Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update. 2017;23(3):300-321. https://doi.org/10.1093/humupd/dmw045
9. Van Dammen L, Wekker V, de Rooij SR, Mol BWJ, Groen H, Hoek A, Roseboom TJ. The effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of life. PLoS One. 2019;14(2):e0212914. https://doi.org/10.1371/journal.pone.0212914
10. Artymuk NV, Sukhova NA, Tachkova, OA, AlJefout M. The Effect of Balanced Hypocaloric Diet on the Anthropometric and Basic Metabolic Indicators in Infertile Women with Gluteofemoral Obesity. Open Journal of Obstetrics and Gynecolog. 2019;9(10):1325-1335. https://doi.org/10.4236/ojog.2019.910128
11. Тачкова О.А., Артымук Н.В., Сутурина Л.В. Случай беременности и родов после хирургического лечения ожирения. Фундаментальная и клиническая медицина. 2018;3(3):97- 100 [Tachkova OA, Artymuk NV, Suturina LV. Pregnancy and delivery after surgical treatment of obesity. Fundamental and Clinical Medicine. 2018;3(3):97-100. (In Russ.).] https://doi.org/10.23946/2500-0764-2019-3-3-97-100
12. Артымук Н.В., Тачкова О.А., Сухова Н.А. Влияние диетотерапии на динамику антропометрических и основных метаболических показателей у бесплодных женщин с ожирением. Акушерство, гинекология и репродукция. 2020;14(1):7-14 [Artymuk NV, Tachkova OA, Sukhova NA. The effect of diet therapy on the anthropometric and metabolic parameters in women with infertility and obesity. Akusherstvo, ginekologia i reprodukcia = Obstetrics, Gynecology and Reproduction. 2020;14(1):7-14. (In Russ.).] https://doi.org/10.17749/2313-7347.2020.14.1.7-14.
13. Uygun B, Kiyici S, Ozmen S, Gul Z, Sigirli D, Cavun S. The Association Between Olfaction and Taste Functions with Serum Ghrelin and Leptin Levels in Obese Women. Metab Syndr Relat Disord. 2019;17(9):452-457. https://doi.org/10.1089/met.2019.0037
14. Malik IA, Durairajanayagam D, Singh HJ. Leptin and its actions on reproduction in males. Asian J Androl. 2019;21(3):296-299. https://doi.org/10.4103/aja.aja_98_18
15. Mishra S, Gupta V, Mishra S, Sachan R, Asthana A. Serum level of orexin-A, leptin, adiponectin and insulin in north Indian obese women. Diabetes Metab Syndr. 2017;11 Suppl 2:S1041-S1043. https://doi.org/10.1016/j.dsx.2017.07.037
16. Farr OM, Gavrieli A, Mantzoros CS. Leptin applications in 2015: what have we learned about leptin and obesity? Curr Opin Endocrinol Diabetes Obes. 2015;22(5):353-359. https://doi.org/10.1097/MED.0000000000000184
17. La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51-58. https://doi.org/10.1016/j.cyto.2016.10.011
18. Zhang Y, Chua S Jr. Leptin Function and Regulation. Compr Physiol. 2017;8(1):351-369. https://doi.org/10.1002/cphy.c160041
19. Kucera R, Babuska V, Ulcova-Gallova Z, Kulda V, Topolcan O. Follicular fluid levels of anti-Müllerian hormone, insulin-like growth factor 1 and leptin in women with fertility disorders. Syst Biol Reprod Med. 2018;64(3):220-223. https://doi.org/10.1080/19396368.2018.1450906
20. Laskowski D, Sjunnesson Y, Humblot P, Andersson G, Gustafsson H, Båge R. The functional role of insulin in fertility and embryonic development-What can we learn from the bovine model?. Theriogenology. 2016;86(1):457-464. https://doi.org/10.1016/j.theriogenology.2016.04.062
21. Macut D, Bjekić-Macut J, Rahelić D, Doknić M. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract. 2017;130:163-170. https://doi.org/10.1016/j.diabres.2017.06.011
22. Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. https://doi.org/10.1186/s12958-018-0336-z
Review
For citations:
Artymuk N.V., Tachkova O.A., Sukhova N.A. Features of the hormonal profile in obese reproductive-age women. Fundamental and Clinical Medicine. 2020;5(3):77-84. (In Russ.) https://doi.org/10.23946/2500-0764-2020-5-3-77-84